Finglobedirect offers Investor Presentations published by Japanese life science companies. These Investor Presentations are compiled by companies to provide strategic input about their business activities along with focus on their financial performance parameters. We provide Investor Presentations (IPs) for Japanese life science companies grouped by various categories for 25 or 50 companies so then users can obtain these presentations right away rather than going through 300 listed companies in the Japanese life science sector.
|
Coverage: We have reviewed the most recent 150+ Investor Presentations complied by Japanese life science companies (including medical devices, pharmaceuticals, biotech, health services, medical technology and related medical supplies companies). Though most of these Investor Presentations were prepared to highlight annual or quarterly earnings of companies, there were many also prepared for a given investor conference or a trade conference or special events set up by companies to provide a strategic view to investors. |
|||
|
Categories of Investor Presentations Available: |
|||
|
Japan Life Sciences 300: Investor Presentations
|
|||
Subscription Fees
$195 for 25 Investor Presentations
Please send us an email for any further queries to info@finglobedirect.com
$850 for all three publications: Japan Life Sciences series on Analysis/Investors Presentations (savings of $245)
- Japan Life Sciences Business 300: Recent Growth and New Directions $500
- Japan Life Sciences 300: Analysis of Quarterly Earnings (ending September 30, 2015) $400
- Japan Life Sciences 300: Investor Presentations( 25 companies) $195
Please send us an email for any further queries to info@finglobedirect.com.